Recapping The Recent Earnings Reports

The last couple weeks have seen a slew of earnings reports and, more importantly, investor update calls from companies in the Tailwinds Universe. Importantly...

Harrow Health, Inc. Letter to Stockholders

Harrow reported earnings on Wednesday, November 13th. They also, for the first time, published a shareholder letter. This letter tells the complete story of...

Show Me The Money

As the stock market hits new highs on all the major indexes seemingly daily, it appears that the market has moved to a “risk...

Harrow Could Be Your Holiday Bonus

As we head into the home stretch of 2019 the market for microcap stocks seems to have turned around. This time last year it...

Volatility Creating Opportunity…

I tend to be very much a buy and hold investor. I take positions, add to them as I gain confidence and generally let...

Fall Investor Preview Along With A Belated August Recap

I’ve held off on my August recap much like a war veteran will refrain from telling tales from the trenches. Not that my experiences...

Harrow: CMS Approves Prescribing Tri-Moxi

Recently the Centers for Medicare & Medicaid Services ("CMS") issued an update to the Hospital Outpatient Prospective Payment System. This updated guidance, that has...

If I Had A Nickel For Every Buying Opportunity…

The path to being a good investor is to be able to see what the future holds and place your bets accordingly. If you...

Trade Alert, August 15, 2019, Harrow

~ Trade Alerts are sent to premium subscribers in real time. This alert was sent out yesterday, however I feel it should be shared...

Harrow Health Announces Second Quarter 2019 Results

NASHVILLE, Tenn., Aug. 14, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the second quarter 2019. Second Quarter 2019 and...

Recapping The Week That Was…And Looking Towards Next

This was a very hectic week in the market, with major swings in the indexes and in our universe of smaller companies. Earnings season...

Harrow Health Forms Stowe Pharmaceuticals Subsidiary to Develop Broad Spectrum Anti-Microbial Ophthalmic and Otic...

Tailwinds' Take: add another subsidiary to the list of companies formed under the Harrow umbrella. Potential market of $2B they are looking to address....

Harrow Health Announces Launch of Mayfield Pharmaceuticals

Tailwinds' Take: the HROW machine just keeps chugging along. Mayfield could be the most exciting spinoff yet, with multi-billion potential. The markets they're going...

Markets Trade Down In May…June Preview

I'm not sure why, but it seems that every time I feel the Tailwinds' Portfolio is poised for big gains, the market enters a...

B Riley, Day One

Today was the first day of the B Riley Conference in Los Angeles at the Beverly Hilton, a hotel that has a 60's feel...

Harrow Comes Out of Allergan Lawsuit Unscathed

In late-breaking news on Thursday afternoon, a jury has ruled in the case of Allergan vs. Imprimis Pharmaceuticals. If you recall, Allergan had been...

Harrow Health Announces First Quarter 2019 Financial Results

SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the first quarter 2019. First Quarter 2019 and...

ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting

SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmology-focused pharmaceutical compounding subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its participation...

Harrow Wins Another Battle In Legal Tussle With Allergan

This week Harrow won a partial summary judgement in their legal tussling with Allergan. This incremental positive supports the companies long-term business model and...

KKR’s Deal With Flying L Validates Harrow

It's always nice when some of the smartest people in the world tell you that what you're doing makes sense. In the case of...
DFC Advisory Services LLC (dba Tailwinds Research) is a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Past performance is not indicative of future performance.